This study examined if the presence of one or more psychiatric disorders influences headache treatment outcomes in patients in headache specialty treatment centers. Using a naturalistic, longitudinal design, 223 patients receiving preventive therapy for headache disorders completed 30-day daily diaries that assessed headache days/month and severity at acute therapy baseline and 6-month evaluation and also provided data on headache disability and quality of life at acute therapy baseline, preventive therapy initiation, preventive therapy adjustment, and 6-month evaluation visits. Psychiatric diagnoses were determined using the Primary Care Evaluation for Mental Disorders (PRIME MDs). Of the 223 patients, 34% (n = 76) had no psychiatric disorder, 21% (n = 46) were diagnosed with Depression-Only; 13% (n = 29) were diagnosed with Anxiety-Only; and 32% (n = 72) were diagnosed with Depression-and-Anxiety. Prior to initiating new preventive therapy, patients with one or more psychiatric disorders reported more frequent and disabling headaches and poorer life quality compared to patients with no psychiatric disorders. Rates of improvement in headache days/month, disability, and quality of life were significant and comparable across the four groups. Contrary to clinical wisdom, patients with psychiatric disorders respond very favorably to contemporary headache treatments administered in headache specialty treatment centers.
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Introduction
Epidemiologic [1, 2, 20, 29, 33] and clinic-based research [5, 7, 26] demonstrates that Depressive-and-Anxiety disorders are common in persons with headache disorders. Headache patients with psychiatric disorders report greater headache frequency, higher rates of multiple-headache diagnoses, increased physical disability, and poorer life quality compared to patients without psychiatric disorders [5, 12, 22] . The headache literature also suggests that the presence of a psychiatric disorder contributes to the chronicity and intractability of headache [17, 23, 24] .
While it is posited that psychiatric comorbidity contributes to poor treatment outcomes in headache [13] [14] [15] 18, 24] , little systematic research has empirically examined the relationship between psychiatric comorbidity and preventive treatment outcomes in headache patients. Two studies [21, 28] suggest that patients with psychiatric comorbid disorders demonstrate greater improvements in headache treatment outcomes relative to patients without psychiatric disorders. However, these studies either assessed psychiatric comorbidity using self-report symptom scales in lieu of DSM-based psychiatric diagnoses [28] or used small convenience samples (n = 16 and n = 52) [21, 28] .
The relationship between psychiatric comorbidity and headache treatment outcomes may also be more complex than it was originally thought to be. Holroyd and colleagues [8] found that improvements in headache activity following treatment with antidepressant medication, stress management therapy, or antidepressant medication plus stress management therapy were not influenced by the presence of a mood or anxiety disorder; however, for the outcome variable of headache disability, the three therapies were more effective in patients with mood or anxiety disorders than in patients with no psychiatric disorders. It must be noted, however, that Holroyd's study was a randomized controlled trial, which assessed the treatment efficacy of only amitriptyline/nortriptyline medications, stress management therapy, and amitriptyline/nortriptyline-plus-stress management, and enrolled only patients with chronic tension-type headache (CTTH). It is unclear if the relationship between psychiatric comorbidity and headache 
